戻る Agenda
Case Study (Non- CE) Hosted By Curavit: Build Regulatory-Grade by Deploying Prospective Linkage and Virtual Sites to Satisfy FDA Standards
Session Chair(s)
Dave Hanaman
President & Co-Founder, Curavit, United States
Retrospective real-world evidence often fails regulatory scrutiny due to data gaps, selection bias, and unresolvable data provenance. To overcome these structural limitations, life sciences organizations must shift to prospective, execution-driven evidence generation. This session presents an integrated blueprint combining virtual clinical sites, instant eligibility screening, and patient-authorized record linkage to capture audit-ready data continuously across multi-year horizons. Attendees will explore real-world case examples demonstrating how to generate defensible, regulatory-grade RWE that satisfies FDA mandates while accelerating trial timelines.